Highly effective CFTR modulator drugs have significantly improved outcomes in pwCF; however, in a few recent studies, they have been shown to have either no effect or a modest effect on the P. aeruginosa burden in the CF lungs and on the hyperinflammatory state (7, 19–21, 78). The gene discussed is CFTR; the disease is cystic fibrosis.